- Home
- GALT vs STRS Comparison
GALT vs STRS Comparison
Compare GALT & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | STRS |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | 9 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 220.4M |
| IPO Year | 2008 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GALT | STRS |
|---|---|---|
| Price | $4.63 | $28.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 42.3K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.84 | ★ 512.50 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $29,914,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.65 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $15.35 |
| 52 Week High | $7.13 | $32.93 |
Technical Indicators
Market Signals| Indicator | GALT | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 72.46 | 43.48 |
| Support Level | $2.75 | $25.91 |
| Resistance Level | $5.21 | $30.05 |
| Average True Range (ATR) | 0.47 | 0.80 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 80.23 | 33.12 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.